u/nikhil_lindqvist

Sceptical. If this were true we would see it reflected in the data and we do not.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Disagree. What you are describing is consistent with purity, not with what you concluded.

What was the dosing schedule in that arm?

Not convinced. The evidence does not support that reading.

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

redact your own name, not the vendor's batch details

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

say how long you were on and at what dose before taper

Disagree but this is the good kind of wrong — it is specific enough to be checked.

Strongly agree. Mass% and area% are answering different questions on the same document.

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Crossposting this to c/glp1muscle because the people who need it are not reading this community.

PDF metadata is checkable in fifteen seconds

tapering instructions are not welcome here

Dated screenshot or is this from memory?

Sent one vial to PeptideMeter and VendorInvestigate. 98.4% and 99.0%. Cost me more than the vial did and I would do it again.

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

Respectfully this is a sample of one presented as a finding.